These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3152506)

  • 1. Current concepts of dose fractionation in radiotherapy. Normal tissue tolerance.
    Hopewell JW; van den Aardweg GJ
    Br J Radiol Suppl; 1988; 22():88-94. PubMed ID: 3152506
    [No Abstract]   [Full Text] [Related]  

  • 2. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of pulmonary tissue on dose distribution in the radiation therapy with fast electrons (author's transl)].
    Afanas'ev BP; Kozlov AP; Justinov SA
    Radiobiol Radiother (Berl); 1981; 22(6):779-86. PubMed ID: 6801723
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial tolerance and time dose fractionation values for common external beam radiation therapy schedules.
    Hibbitts KR; Miller MP; Raeside DE; Bogardus CR
    Radiol Technol; 1981; 52(5):533-42. PubMed ID: 6801724
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractionation--a review of the clinical data.
    Dische S; Saunders MI
    Br J Radiol Suppl; 1988; 22():84-7. PubMed ID: 3152505
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy of soft tissue sarcomas].
    Franke HD; Langendorff G; Schmidt R; Böcker W
    Chirurg; 1983 Oct; 54(10):652-9. PubMed ID: 6432489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal tissue tolerance dose metrics for radiation therapy of major organs.
    Milano MT; Constine LS; Okunieff P
    Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapy.
    Holt RW; Rivard MJ
    J Am Coll Radiol; 2008 Mar; 5(3):221-3. PubMed ID: 18312972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cancer and radiotherapy. (6) Present status and problems of radiotherapy].
    Tsunemoto H
    Iyodenshi To Seitai Kogaku; 1983 Feb; 21(1):36-47. PubMed ID: 6314002
    [No Abstract]   [Full Text] [Related]  

  • 13. Basic principles of radiobiology, radiotherapy, and radiosurgery.
    Shrieve DC; Klish M; Wendland MM; Watson GA
    Neurosurg Clin N Am; 2004 Oct; 15(4):467-79, x. PubMed ID: 15450882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy charged particle irradiation of human cancers.
    Castro JR
    Radiat Med; 1983; 1(1):70-5. PubMed ID: 6436908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
    Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
    Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy of metastatic brain tumors].
    Mikhina ZP; Glekov IV
    Med Radiol (Mosk); 1984 Jun; 29(6):53-9. PubMed ID: 6429472
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
    Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symposium: Heavy particles in radiotherapy].
    Radiol Med; 1984 Apr; 70(4 Suppl 1):127-37. PubMed ID: 6097953
    [No Abstract]   [Full Text] [Related]  

  • 19. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with proton beam radiation therapy.
    Suit HD; Goitein M; Munzenrider JE; Verhey L; Gragoudas E; Koehler AM; Urano M; Shipley WU; Linggood RM; Friedberg C; Wagner M
    J Can Assoc Radiol; 1980 Mar; 31(1):35-9. PubMed ID: 6245096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.